359 related articles for article (PubMed ID: 18548983)
1. Real-life effectiveness of Singulair (montelukast) in 506 children with mild to moderate asthma.
Amirav I
Isr Med Assoc J; 2008 Apr; 10(4):287-91. PubMed ID: 18548983
[TBL] [Abstract][Full Text] [Related]
2. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
Wahn U; Dass SB
Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
[TBL] [Abstract][Full Text] [Related]
3. [Utilization and clinical validation of the Spanish version of the Pediatric Asthma Quality of Life Questionnaire (PAQLQ) and the Diary for Caregivers of Asthmatic Children (DCA). VALAIR study].
Alonso Lebrero E
Allergol Immunopathol (Madr); 2000; 28(3):175-83. PubMed ID: 10867390
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of montelukast monotherapy in moderate persistent asthmatic children.
Igde M; Anlar FY
Iran J Allergy Asthma Immunol; 2009 Sep; 8(3):169-70. PubMed ID: 20124610
[TBL] [Abstract][Full Text] [Related]
5. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
Virchow JC; Bachert C
Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
[TBL] [Abstract][Full Text] [Related]
8. Montelukast in asthmatic patients 6 years-14 years old with an FEV1 > 75%.
Becker A; Swern A; Tozzi CA; Yu Q; Reiss T; Knorr B
Curr Med Res Opin; 2004 Oct; 20(10):1651-9. PubMed ID: 15462699
[TBL] [Abstract][Full Text] [Related]
9. Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline.
Allen-Ramey FC; Duong PT; Riedel AA; Markson LE; Weiss KB
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):373-80. PubMed ID: 15521374
[TBL] [Abstract][Full Text] [Related]
10. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
Sorkness CA; Lemanske RF; Mauger DT; Boehmer SJ; Chinchilli VM; Martinez FD; Strunk RC; Szefler SJ; Zeiger RS; Bacharier LB; Bloomberg GR; Covar RA; Guilbert TW; Heldt G; Larsen G; Mellon MH; Morgan WJ; Moss MH; Spahn JD; Taussig LM;
J Allergy Clin Immunol; 2007 Jan; 119(1):64-72. PubMed ID: 17140647
[TBL] [Abstract][Full Text] [Related]
11. [Effect of the leukotriene receptor antagonist montelukast therapy on asthma in childhood].
Zsigmond G; Novák Z; Kósa L
Orv Hetil; 2004 Nov; 145(48):2431-5. PubMed ID: 15638037
[TBL] [Abstract][Full Text] [Related]
12. Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children.
Moeller A; Lehmann A; Knauer N; Albisetti M; Rochat M; Johannes W
Pediatr Pulmonol; 2008 Feb; 43(2):179-86. PubMed ID: 18085698
[TBL] [Abstract][Full Text] [Related]
13. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.
Zeiger RS; Szefler SJ; Phillips BR; Schatz M; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM;
J Allergy Clin Immunol; 2006 Jan; 117(1):45-52. PubMed ID: 16387583
[TBL] [Abstract][Full Text] [Related]
14. [Preventive monotherapy with montelukast versus DNCG in children with mild asthma. Results of and exploratory pilot study].
Liebke C; Sommerfeld C; Wahn U; Niggemann B
Pneumologie; 2001 May; 55(5):231-7. PubMed ID: 11449608
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness and safety of montelukast versus budesonide at various doses on bronchial reactivity in subjects with mild persistent asthma].
Riccioni G; D'Orazio N; Di Ilio C; Della Vecchia R; De Lorenzo A
Clin Ter; 2002; 153(5):317-21. PubMed ID: 12510415
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of montelukast as monotherapy in children with mild persistent asthma.
Ghosh G; Manglik AK; Roy S
Indian Pediatr; 2006 Sep; 43(9):780-5. PubMed ID: 17033116
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of montelukast and airway mast cell profiles in patients with cough variant asthma.
Kawai S; Baba K; Matsubara A; Shiono H; Okada T; Yamaguchi E
J Asthma; 2008 Apr; 45(3):243-50. PubMed ID: 18415834
[TBL] [Abstract][Full Text] [Related]
18. A clinical trial of the efficacy and safety of montelukast as monotherapy in patients with chronic stable bronchial asthma.
Athavale A; Souza GA; Avasthi R; Singh NP; Kale M; Taneja A; Sireesha K
J Indian Med Assoc; 2004 Feb; 102(2):109-11. PubMed ID: 15200214
[TBL] [Abstract][Full Text] [Related]
19. Patterns of asthma-related health care resource use in children treated with montelukast or fluticasone.
Allen-Ramey FC; Markson LE; Riedel AA; Sajjan S; Weiss KB
Curr Med Res Opin; 2006 Aug; 22(8):1453-61. PubMed ID: 16870071
[TBL] [Abstract][Full Text] [Related]
20. Montelukast in general pediatric practices.
Ngamphaiboon J
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S348-51. PubMed ID: 16623053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
